Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects

NCT01270984

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +18 more
Locations: The Korea University Anam Hospital Seoul, South Korea

View Trial Details

Completed

A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide

NCT00005793

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

NCT00003938

Conditions: Adnexal Diseases, Agranulocytosis, Amyloidosis, +147 more
Locations: A.Z. St. Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

View all 24 locations

View Trial Details

Completed

Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count

NCT00003805

Conditions: Blast Crisis, Blood Protein Disorders, Body Temperature Changes, +69 more
Locations: Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States

Boston Medical Center Boston, Massachusetts, United States

Algemeen Ziekenhuis Middelheim Antwerp, Belgium

Hopital Universitaire Erasme Brussels, Belgium

View all 28 locations

View Trial Details

Completed

Safety and Efficacy of Imatinib in Chronic Myelogenous Patients in Relapse After Stem Cell Transplantation

NCT00219726

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: University Hospital Poitiers, France

View Trial Details

Completed

Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia

NCT00052299

Conditions: Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung Linz, Austria

Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria

AZ Sint-Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

View all 55 locations

View Trial Details

Completed

Ph II Study of Azacitidine in Myelofibrosis

NCT00569660

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Phase II Study of CC-5013 in Myelofibrosis

NCT00087672

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease

NCT00267085

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +14 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

NCT00002547

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +21 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions